Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pathog Dis ; 76(1)2018 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-29272378

RESUMO

The aim of the present study is to estimate the protective efficacy of Brucella abortus lysed cells by GI24 against brucellosis in Beagles. Group A was subcutaneously (sc) immunized with sterile phosphate-buffered saline, and group B was sc immunized with approximately 3 × 109 of the lysed cells. Brucella-LPS-specific serum IgG titers and IL-4, TNF-α and IFN-γ concentrations were investigated by enzyme linked immunosorbent assay. All dogs were intraconjunctivally challenged with B. abortus strain 544 at 6 weeks post-prime immunization. The serum IgG titers were considerably higher in group B than in group A. The levels of IL-4, TNF-α and IFN-γ in group B than in group A were significantly higher. Following challenge, no challenge strain was observed from all tissues of three dogs of group B. However, challenge strain was detected from spleen, uterus (except one Beagle) and inguinal and retropharyngeal lymph nodes of all group A Beagles. The results of this study demonstrated that sc immunization with the lysed cells induced robust antibody and cell-mediated immune responses in Beagles. The lysed cells also conferred protection against infection with B. abortus. These results suggest that sc immunization with B. abortus lysed cells by GI24 is a good vaccine candidate against brucellosis in dogs.


Assuntos
Vacina contra Brucelose/imunologia , Brucelose/veterinária , Doenças do Cão/prevenção & controle , Estruturas Animais/microbiologia , Animais , Anticorpos Antibacterianos/sangue , Vacina contra Brucelose/administração & dosagem , Vacina contra Brucelose/isolamento & purificação , Brucelose/microbiologia , Brucelose/patologia , Brucelose/prevenção & controle , Bovinos , Cães , Ensaio de Imunoadsorção Enzimática , Imunoglobulina G/sangue , Injeções Subcutâneas , Interferon gama/sangue , Interleucina-4/sangue , Fator de Necrose Tumoral alfa/sangue , Vacinas de Produtos Inativados/administração & dosagem , Vacinas de Produtos Inativados/imunologia , Vacinas de Produtos Inativados/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA